Reviews the latest findings on the epidemiology, molecular and genetic features of ATL
Provides discussions on new treatment methods for ATL and infection prevention for HTLV-1
Prepared by authoritative editors in Japan, a major restricted endemic area
This book provides essential information on the epidemiology, molecular and genetic features, anti-CCR4 antibody therapy and a nationwide study of transplantation on human T-leukemia virus type-I (HTLV-1) and adult T-cell leukemia/lymphoma (ATL). This rare but important disease hasrestricted endemic areas and distinct clinical features such as a high frequency of hypercalcemia, strong predisposition to infection and poor response to chemotherapy, aspects which set ATL apart from other types of non-Hodgkin lymphoma. Given the small number of patients, enrollmentin clinical trials has not been feasible, and establishing treatment standard has been difficult but new evidence, such as results of nationwide studies on transplantation, have shown new insights and potential treatments. Based on recent evidence, the book presents new treatment methodsfor ATL and infection prevention of HTLV-1, enabling clinicians, researchers and post-docs specializing in hematology and virology to gain a valuable overview of the disease.
Prof. Toshiki Watanabe
Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo
Prof. Takuya FukushimaSchool of Health Sciences, Faculty of Medicine, University of the Ryukyus